BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 28, 2008
 |  BioCentury  |  Finance

EPS watch

EPS watch

Company 4Q07 EPS est 4Q07 EPS actual Outcome Growth from 4Q06 1/25 cls Wk chg % chg Mcap chg 1/25Mcap
Abbott (NYSE:ABT) $0.92 $0.93 Beat by $0.01 24% $55.48 -$3.95 -7% -$6,172.5 $86,696.6
Fourth quarter sales increased 16.1% to $7.2B from $6.2B in 4Q06. The company gave earnings guidance of $3.20-$3.25 for FY08 and $0.61-$0.63 for 1Q08. All figures include foreign currency exchange impact.
Actelion (SWX:ATLN) NA NA NA NA CHF56.00 CHF0.25 0% $24.7 $6,141.2
Actelion reported preliminary revenues, which showed that overall sales jumped 42% to CHF370.9M ($327.4M) from CHF261.4M ($214.4M). Sales of Tracleer bosentan for...

Read the full 648 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >